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Abstract
Children in malaria endemic areas acquire immunity to severe malaria faster than to mild malaria. Only a minority of children
suffers from severe malaria and it is not known what determines this. The aim of this study was to establish how P.
falciparum infections during the first years of life affect the risk of severe malaria. A matched case-control study was nested
within a large birth cohort set up to study the immunoepidemiology of pneumococci on the Kenyan coast. Infection
patterns in three-monthly blood samples in cohort children admitted to hospital with severe malaria were compared to
controls matched on age, residential location and time of sampling. P. falciparum detected at least once from birth
conferred an increased risk of severe malaria and particularly if multiclonal infections, as characterized by genotyping of a
polymorphic antigen gene, were ever detected. The results show for the first time that children with severe malaria have
more infections early in life compared to community controls. These findings provide important insights on the immunity to
severe disease, knowledge essential for the development of a vaccine against severe malaria.
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Introduction
Severe P. falciparum malaria continues to cause an intolerably
high burden of morbidity and mortality on children living in
malaria endemic areas [1]. In areas of high transmission, life-
threatening forms of malaria are restricted to young children
before they gradually develop clinical protection after repeated
exposure. Understanding how immunity to severe manifestations
of malaria develops is important in designing interventions to
reduce severe disease and death.
The age distribution of severe malaria indicates that resistance
to serious complications develops much earlier than immunity to
uncomplicated and asymptomatic infections [2]. One possibility is
that within an age cohort the individuals who develop severe
disease are relatively naı¨ve by virtue of the pattern of exposure to
malaria that they experience in early life. The number of infections
needed to achieve protection against severe malaria is however not
clear. Protection against non-cerebral severe malaria has been
proposed to be acquired after only a few infections, and even after
a single infection in infants with transferred maternal antibodies
[3]. Prospective risk assessments of severe malaria in relation to
exposure require large cohorts to capture the relatively rare event
of severe disease and have not previously been reported.
Three major syndromes of severe malaria have been identified
in children: cerebral malaria severe malarial anemia, and
respiratory distress as a sign of acidosis [4]. Cerebral malaria is
predominant in areas of low to moderate transmission and peak
incidence occurs in children older than 2 years [2], [5], [6].
Cerebral malaria is also one of the most common severe features in
previously non-immune adults [7] and in outbreaks of malaria in
areas inhabited by a previously un-exposed population [8]. Severe
malarial anemia is reported in highly endemic areas affecting
mainly young children around the age of 1 year [2]. Respiratory
distress with deep breathing has been shown to be a good ‘‘proxy’’
for metabolic acidosis and an indicator of severity [4].
The P. falciparum parasite is a highly polymorphic organism with
an extensive genetic diversity and natural infections are often
composed of several genetically distinct clones expressing different
antigen variants. Based on the knowledge from malaria therapy of
neuro-syphilis [9] as well as animal models [10], protective
immunity to malaria is considered to have a substantial degree of
‘‘strain-specificity’’ reflected by more pronounced clinical symp-
toms in individuals infected with a new ‘‘strain’’. Whether
immunity to severe malaria develops in a strain-transcending
manner remains unclear, as does the number of different parasite
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variants that needs to be encountered to acquire protection. A
well-established method to characterize P. falciparum populations is
by genotyping the highly polymorphic merozoite surface protein-2
gene (msp2), encoding a thoroughly studied potential vaccine
candidate antigen [11]. Since the parasite is haploid in the human
host, clones i.e. genetically identical sets of blood-stage parasites
derived from the same progeny, will have the same msp2 genotype
and different infections can be studied within individuals over
time.
The aim of this study was to investigate whether the pattern of
exposure and particularly number of infections and different
clones in early childhood affect the risk of severe malaria. A large
birth cohort established in Kilifi District on the coast of Kenya,
offered the opportunity to study the infection patterns from birth
in relation to severe malaria outcome. In a nested case-control
design we have investigated the parasite prevalence and the
number and types of P. falciparum msp2 genotypes in three-monthly
samples collected from birth in cohort children who subsequently
were admitted with severe malaria and from controls matched for
age, time of sampling and area of residency. Moreover, serum
samples were analysed with regards to antibodies to whole P.
falciparum schizont extract as a marker of previous parasite
exposure [12], [13].
Materials and Methods
Study Setting
The study was conducted in Kilifi District along the Kenyan
coast. Approval for the study was granted by the Kenyan Medical
Research Institute National Ethics Committee and the Central
Ethical Review Board Stockholm, Sweden. Kilifi District is
mesoendemic for P. falciparum malaria and transmission typically
has two seasonal peaks (June-August and November-December).
Spatial differences in transmission intensity and entomological
inoculation rate in the area have been described [14] and malaria
morbidity and mortality decreased markedly between 2000 and
2007 [15].
Kilifi District Hospital (KDH) serves as a first referral centre for
more than 500 000 people. All children admitted to KDH are
investigated with a malaria slide and blood cultures, except those
admitted after accidents or for elective procedures. Clinical and
laboratory data are recorded systematically at admission.
The Kilifi Health and Demographic Surveillance system
(KHDSS), established in 2000, covers 891 km2 around KDH
and currently tracks a population of about 240000 people. All
homesteads in KHDSS are visited 4–6 monthly to collect
information on births, migrations and deaths [16].
Study Population and Cohort Visits
A birth cohort, the Kilifi Birth Cohort (KBC) was set up within
the KHDSS in 2001 to study the immunoepidemiology of
pneumococcal disease. Children either born at KDH or presenting
to the vaccination clinic within their first month of life were
recruited and subsequently followed with three-monthly visits for
two years. The study was explained to parents or guardians by
team members fluent in Swahili or Giriama and parents were also
given written versions of the information. At each visit, axillary
temperature was recorded together with sampling of 2 ml venous
blood (without anticoagulant) and a thick and thin film for malaria
microscopy. The blood samples were centrifuged and blood clots
and serum samples were stored at 280uC. Children unwell during
the study visits were attended to by medical staff and referred to
KDH. Parents/guardians who did not bring their children for
follow-up visits were visited in their homes the following day and
again invited to attend the three-monthly sampling.
Severe Malaria Cases and Controls
A matched case-control study was nested within the Kilifi Birth
Cohort. Cases were children admitted to KDH between April
2002 and January 2010 with P. falciparum parasites detected by
microscopy together with either one or more of the following signs
(syndromes) (1) impaired consciousness defined as Blantyre Coma
Score ,5 [17]; (2) severe anemia defined as hemoglobin ,5g/dl
[4]; and/or (3) deep breathing and/or chest indrawing i.e.
respiratory distress as a sign of acidosis [4], [18]. Children with
positive bacterial cultures from blood or cerebrospinal fluid and/
or .10 white blood cells in cerebrospinal fluid were excluded to
avoid misclassification of children with other infections and
incidental parasitemia [19].
Controls were cohort children who had not developed severe
malaria up to the time point when the matched case had its
episode, and who were individually matched to cases on age (+/
24 months), sampling time (+/23 months) and residential
location. Three controls were sought for each case.
Detection of P. falciparum by Microscopy
Thick and thin blood films were prepared from finger prick
blood and stained with Giemsa. Slides were examined under light
microscopy and parasites were counted against 200 leukocytes or
500 erythrocytes. P. falciparum densities were defined as the
number of asexual parasites/ml of whole blood, based on an
estimated leukocyte count of 8000/ml or 5 million erythrocytes/ml,
respectively. Each blood film was evaluated separately by two
expert microscopists and discrepancies resolved by the results from
a third microscopist. The slides from the cohort visits were read
during 2010. Slides taken at the time of admissions were read
promptly as part of the acute clinical management.
Genotyping of P. falciparum Infections
DNA was extracted by processing frozen blood clots by high-
speed shaking in a cell disruptor [20] followed by extraction with
Puregene kits (Qiagen). Genotyping of the polymorphic block 3 of
the msp2 gene was performed by fluorescent PCR followed by
capillary electrophoresis [21]. In brief, the PCR included an initial
amplification of the outer msp2 domain, followed by two separate
nested reactions with fluorescent primers targeting the two allelic
types of msp2: FC27 and IC (also referred to as 3D7), and fragment
analysis in a DNA sequencer (3730, Applied Biosystems) and
GeneMapper software (Applied Biosystems).
Antibody Assay
Antibodies against P. falciparum schizont extract were assessed by
Enzyme-linked immunosorbent assay (ELISA) using the A4
parasite line [12], [13]. Test samples were scored as positive if
the OD values were above the mean+3 SD of 20 European sera.
Statistical Analysis
Statistical analyses were performed using PRISM GraphPad
and R version 2.13.1. Parasite prevalence at the cohort visits was
based on results from microscopy as well as PCR genotyping of the
P. falciparum msp-2 gene depending on availability of samples. The
number of concurrent clones was categorized as 1 clone or $2
clones (i.e. multiclonal infections). Patterns of infections in three-
monthly samples were defined in three categories; parasite
negative in all samples, parasite positive with single clone and
parasite positive with multiple clones in at least one sample.
Infection Patterns and Risk of Severe Malaria
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Conditional logistic regression, including risk sets where at least
one matched control was available for each case, was used to
analyze the risk of being a case given previous parasite exposure.
This analysis included the 42 risk sets where the case was no older
than 2 years and 3 months at the time of severe malaria episode
and thus had samples until three months before the admission.
The analyses were adjusted for the logarithm of the number of
visits, which was approximately linearly related to the logarithm of
the odds of becoming a case. An unconditional case-control study
was performed within the 61 cases according to syndrome; severe
malaria with impaired consciousness versus non-cerebral severe
malaria, using an exact logistic regression due to the small sample
size, with a model adjusted for age (in six-month categories) and
number of visits.
Results
In total 5949 children were recruited into the Kilifi Birth
Cohort between March 2001 and March 2008; of which 1637
children (28%) had been admitted to Kilifi District Hospital until
January 2010. In 265 of the total 2366 (11%) admissions, a blood
film was positive for P. falciparum, and 93 children (4% of all
admissions, 35% of admissions with parasites) fulfilled the criteria
of severe malaria by a strict syndrome definition (Figure 1). Among
these, 61 children had three-monthly samples collected prior to
admission; 42 children with one of the three syndromes (impaired
consciousness, severe anemia, respiratory distress), 14 with two
and 5 children presenting with all three syndromes (Figure 2). No
child in the cohort was admitted with severe malaria more than
once. Four children died at the time of the severe malaria
admission. The median age at admission was 14.8 months (IQR
7.5–24.5) and varied over time (Figure S1) and did not differ
between children with or without impaired consciousness.
Matched controls were available within the cohort for 55 of the
61 cases (52 cases with 3, 2 cases with 2 and 1 case with 1 control,
respectively). The degree of matching is demonstrated in Table 1.
Parasite Patterns at Three-monthly Visits and Severe
Malaria Admission
P. falciparum parasites were detected by PCR or microscopy in at
least one of the three-monthly visits in 33% of the cases and 15%
of the controls (Table 1). Among the PCR positive samples, most
were composed of a single msp2 genotype i.e. clone (65% and 70%
in cases and controls, respectively). The number of clones in
multiclonal infections ranged from 2–3 clones in the cases and 2–6
clones in the controls. The cumulative number of clones, including
all samples, ranged from 0–6 in cases and 0–15 clones in controls.
The number of clones was not correlated to parasite densities
(r =20.25, P=0.33). Children admitted with impaired conscious-
ness had only one single clone in samples prior to admission;
whereas children with respiratory distress and/or anemia (without
impaired consciousness) had up to 6 clones cumulatively in three-
monthly visits.
Hospital admission samples from the admission sample archives
were available for genotyping in 40 of 61 cases. For 21 cases,
admission samples had either not been collected or had been used
in other studies. Single clones were detected in 52%, and the
multiclonal infections were composed of 2 or 3 clones. None of the
cases had been infected with the exact same msp2 allele (same type
and fragment size) before admission and 5 of 10 cases had a new
msp2 allelic type (FC27 or IC) at admission. The same alleles (at bp
precision) were detected in consecutive three-monthly visits in 3
control children (illustrated in File S1). Additional information of
msp2 genotyping profiles and allele frequencies in visits and
admissions are presented in the Supporting information (Figure S2
and File S1).
Exposure and Risk of Severe Malaria
Detection of P. falciparum parasites in at least one of the visits
predicted, compared to only negative visits, an increased risk of
admission with severe malaria (OR 3.70, 95% CI 1.25–10.92,
P=0.018) and particularly if a multiclonal infection was ever
detected (OR 15.32, 95% CI 1.49 2157.40 P= 0.022) (Table 2).
Parasite positivity in the most recent sample before admission gave
a similar odds ratio as parasite positivity at any time (OR 3.62,
95% CI 0.84–15.71, P= 0.085). Assessment of the risk of severe
malaria with regards to parasite status at different ages, number of
parasite positive visits, or to cumulative number of clones was
restricted by limited data for subgroup analysis.
Antibodies against P. falciparum schizont extract (assessed as a
marker of ever being exposed) were detected in at least one of the
three most recent samples before admission, in 75% of cases and
70% of controls, respectively (Table 1). Children with parasite
positive visits were all antibody positive, except five children (one
with fever). There was no association between detection of anti-
schizont antibodies and severe malaria (OR 0.76, 95% CI 0.30–
1.89).
Exposure was further assessed with regards to the different
syndromes of severe malaria. Anti-schizont antibodies were
detected before admission in three-monthly samples in 59% of
children with impaired consciousness and 86% of children with
respiratory distress and/or anemia (without impaired conscious-
ness) (Table 3). Within a comparison among the 61 cases with
severe malaria the odds of having impaired consciousness was
lower if antibodies were ever detected (OR 0.15, 95% CI 0.03–
1.23, Table 4).
Discussion
In this matched case-control study nested within a birth cohort
on the coast of Kenya, detection of P. falciparum infections,
especially infections with multiple clones, in three monthly samples
during the two first years of life was associated with an increased
risk of admission with severe malaria. The infection patterns in the
cohort children who had been admitted to hospital with severe
malaria were compared to the profiles in children of the same age,
residential location and time of sampling. Although the back-
ground cumulative parasite rates were relatively low, detection of
antibodies to schizont extract suggested an overall high exposure
to P. falciparum parasites in both cases and controls. This high
seroprevalence confirms that a majority of cases had been exposed
to P. falciparum prior to the severe disease episode, thus arguing
against the notion that severe malaria occurs predominantly after
first encounters with the parasite.
The three-monthly assessments provide only snapshots of the
infection dynamics [22] and data were not available on the
incidence of mild malaria and the frequency of antimalarial
treatment. The number of infections in these children is thus likely
to be underestimated. One interpretation of the higher prior
parasite positivity among the cases is that this simply reflects higher
exposure, due to local heterogeneity in transmission, i.e. ‘‘hot
spots’’ [23].
However, the finding of similar and high rates of preexisting
antimalarial antibodies in the closely matched cases and controls
indicates that similar proportions of children have been exposed to
P. falciparum at least once. In the youngest children, antibodies
might have been partly maternally derived and a more in depth
Infection Patterns and Risk of Severe Malaria
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analysis of the dynamics of anti-malarial antibodies in these
children is ongoing.
An alternative explanation for the more frequent prior detection
of parasites in children developing severe malaria is that it reflects
less good control of parasite densities in those individuals following
exposure to malaria. It should be noted that most prior infections
were asymptomatic at the cohort visits suggesting a state of partial
immunity, at least to the infecting parasite. Children thus succumb
Figure 1. Matched case-control study profile.
doi:10.1371/journal.pone.0056032.g001
Infection Patterns and Risk of Severe Malaria
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to severe malaria despite having previously been able to harbor
parasites without fever. We therefore tested whether subsequent
episodes of severe disease represented exposure to new infections.
Genotyping of the msp2 gene provides more sensitive and
detailed data on different P. falciparum populations than just
assessing parasite prevalence by microscopy or PCR. The
genotyping confirmed that the infections at the time of the severe
malaria admissions were all different from the parasites detected in
previous three-monthly visits. The finding of multiclonal P.
falciparum infections in the cohort visits might be a result of several
genotypes transmitted in single mosquito inoculations but can also
reflect accumulation of repeated infections. However, most PCR
Figure 2. Syndromes overlap and mortality among the 61 cohort children admitted with severe malaria to Kilifi District Hospital.
Four children died (marked *).
doi:10.1371/journal.pone.0056032.g002
Table 1. Characteristics of the study population.
Characteristics Cases (n =61) Controls (n =161)
Sex female, n (%) 31 (51) 78 (48)
Age (months) at the time of case admissiona, mean (range) all 19.3 (1.9–37.0) 19.5 (1.6–37.5)
42 risk setsb 12.5 (3.9–26.9) 12.5 (2.3–28.2)
Number of three-monthly visits per child, mean (range) 2.77 (1–8) 3.09 (1–8)
Proportion parasite positive visitsc, n (%) 17/150 (11) 30/432 (7)
Proportion of children with at least one parasite positive visitc, n (%) 20/61 (33) 25/161(15)
Proportion of children with at least one antibody positive visitd, n (%) 44/61 (75) 105/161 (70)
Visits with fever, n (% of visits) 9/169 (5.3) 27/498 (5.4)
Visits with fever and parasites (by microscopy), n (% of visits) 2/169 (1.2) 10/498 (2.0)
a. age at case admission of the cases and respective controls.
b. restricted to the 42 risk sets where case was younger than 2 years and 3 months at the severe malaria admission and thus had complete follow up periods before
admission,
c. including PCR and microscopy results.
d. antibodies to schizont extract detected in at least one of the three most recent visits before admission in the cases and corresponding time in the controls.
doi:10.1371/journal.pone.0056032.t001
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positive samples in these children were composed of single clones.
Also in high transmission areas where infections are mainly
multiclonal, children younger than 1 year are more often infected
with fewer clones [24], [25] and duration of infections and number
of concurrent clones increase with age [25], [26].
The risk of severe malaria was highest in children who had a
multiclonal infection detected in at least one sample since birth. In
previous studies of uncomplicated malaria from this and other
areas of low or moderate transmission intensity, multiclonal
infections in asymptomatic individuals at base line have predicted
an increased risk of subsequent malaria [27-29]. In high
transmission settings and in older children detection of multiple
P. falciparum clones has, on the contrary, been associated with a
reduced risk of uncomplicated malaria [29], [30]. The contradic-
tory findings could be explained by the idea that in young children
with limited acquired immunity, multiple clones reflect either
higher degrees of exposure to malaria or less good immune
control. As argued above, data on antibody prevalence suggest the
latter. In a recent study, the cumulative number of clones in
repeated samples, defined as ‘‘molecular force of infection’’, was
found to be a major factor determining the risk of clinical malaria
in children up to three years of age and was suggested as measure
of individual exposure [31]. How and when the transition from
susceptibility to protection against clinical malaria occurs in an
Table 2. Risk of severe malaria associated with parasite
positivity, number of clones and antibodies to schizont extract
in three-monthly visits before admission.
Exposure OR (95% CI)b P
Negative in all 1 (ref) –
Parasite positive in anyc 3.70 (1.25–10.92) 0.018
Negative in all 1 (ref) –
At most 1 clone d 4.30 (1.12–16.46) 0.033
$2 clones in any sample d 15.32 (1.49–157.40) 0.022
Negative in all 1 (ref) –
Antibody positive in any e 0.76 (0.31–1.89) 0.558
Conditional logistic regression adjusted for log number of visits including 42
risk sets where the case was no older than 2 years and 3 months at the time of
severe malaria episode and thus had samples until three months before the
admissiona.
a. excluding 13 risk sets with children with longer time since their last visit (4–47
months).
b. adjusted for log number of visits in the period before the severe admission of
the cases and respective periods in the controls.
c. including PCR and microscopy results.
d. including only risk sets where PCR results were available (n = 41).
e. antibodies to schizont extract detected in at least one of the three most
recent visits before admission in the cases and corresponding time in the
controls, including 40 risk sets where samples for antibody analysis were
available.
doi:10.1371/journal.pone.0056032.t002
Table 3. Assessment of exposure in three-monthly visits from birth until admissiona in 61 children admitted with severe malaria.
Impaired consciousnessb
n(%) Non-cerebral malariac n (%)
Number of children 32 29
Parasite positive visits 0 25 (78) 19 (65)
1 7 (22) 8 (28)
2 0 2 (7)
Proportion positive 7 (22) 10 (34)
Number of clones in PCR positive visits Only 1 cloned 6 (19) 5 (17)
Ever multiclonal 0 5 (17)
Cumulative numbere, median (range) 1 (1–1) 2 (1–6)
Antibody positive visits Proportion positive 19/31 (62) 25/28 (89)
Exposedf 20/32 (63) 25/29 (86)
Not exposedg 12/32 (37) 4/29 (14)
a. samples until 2 years of age at most.
b. cases with impaired consciousness with or without other syndromes.
c. including respiratory distress and severe malaria anemia and not impaired consciousness.
d. ever detected in all samples.
e. total number of clones detected in an individual including all visits.
f. exposed (parasite positive and/or antibodies to schizont extract at least once) n (%).
g. not exposed as determined by PCR and antibodies to schizont extract.
doi:10.1371/journal.pone.0056032.t003
Table 4. Risk of impaired consciousness in relation to parasite
exposure in three-monthly samples among 61 cases with
severe malaria.
Exposure OR (95% CI) P
Ever parasite positive a 0.50 (0.08–2.49) 0.46
Ever multiple clones b 0.44 (0–4.91) 0.51
Ever antibody positive c 0.15 (0.03–1.23) 0.06
Unmatched case-control analysis performed with exact logistic regression
adjusted for age and number of samples, defining patients with impaired
consciousness as ‘‘cases’’ (n = 32) and those with non-cerebral severe malaria as
‘‘controls’’ (n = 29).
a. including PCR and/or microscopy results.
b. including only PCR results.
c. antibodies to schizont extract detected in at least one of the three most
recent visits before admission in the cases and corresponding time in the
controls.
doi:10.1371/journal.pone.0056032.t004
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individual with regards to exposure to different parasite variants
remains to be established.
The design of this study was unique in the sense that the three-
monthly sampling within this large birth cohort allowed for
genotyping of the infections encountered before the episodes of
severe malaria. Although the study was running over several years,
only a limited number of children had developed severe malaria
within the cohort. Since Kilifi District Hospital is the only referral
hospital in the district and the systematic recording of all pediatric
hospital admissions is well established, we believe that the linkage
was successful in capturing the majority of admissions of severe
malaria within the cohort. Only including children with the major
syndromes of severe malaria restricted the number of cases,
however a high specificity was achieved [4]. The relatively low
number of cases identified within the cohort reflects the decline of
malaria transmission in the study area [15]. Matching for location,
age and season (+/23 months) was thus highly important to
control for regional and temporal differences in transmission in
Kilifi District during the study period.
Immunity to severe non-cerebral malaria has been suggested to
be acquired after only one or two infections [3]. Here, none of the
cases were parasite positive in more than two three-monthly
samples before admission. Nonetheless, up to six different clones
were detected over time before admission in children with severe
non-cerebral malaria. In contrast, the children who developed
severe malaria with impaired consciousness never had more than
one clone prior to admission, thus suggesting different force of
infection. Further analysis with regards to the different severe
malaria syndromes was limited by the number of cases for
subgroup analysis. Nonetheless in addition to having no detected
prior multi-clonal infections, children with impaired consciousness
also were less likely than children with other forms of severe
disease to have evidence of exposure as judged by antimalarial
antibodies. Children admitted with impaired consciousness might
be those who either developed severe complications during their
first infection or those that did not acquire appropriate immune
responses during earlier infections.
Knowledge of how and when children develop protective
immunity to severe malaria is important for the development of a
vaccine and important also for design of other control measures.
Although findings need to be confirmed, the results suggest that
infection patterns differ between children who develop severe
malaria when compared with children who do not, and also may
differ in children who develop different syndromes of severe
malaria. Although epidemiological evidence shows that immunity
develops faster to severe than to mild disease, our results argue
against the notion that children who succumb to severe malaria
are previously naı¨ve to the infection.
Supporting Information
Figure S1 Distribution and mean age at admissions
with severe malaria within the cohort during the study
period 2002–2010. Severe malaria admissions were included up
to 2010, i.e. 2 years after inclusions ended.
(TIF)
Figure S2 Distribution of alleles of A) FC27 types and B)
IC types in admissions and three-monthly visits. The y-
axes determine the number of alleles of the same fragment length
at base pair precision.
(TIF)
File S1 Additional information of msp2 genotyping
profiles and allele frequencies in visits and admissions.
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